Trial Identifier: | D933LC00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03742102 |
Start Date: | December 2018 |
Primary Completion Date: | June 2023 |
Study Completion Date: | June 2023 |
Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CA, BC | Kelowna, BC, CA, V1Y 5L3 |
CA, ON | London, ON, CA, N6A 5W9 |
CA, ON | Toronto, ON, CA, M4N 3M5 |
CA, QC | Greenfield Park, QC, CA, J4V 2H1 |
CA, QC | Montreal, QC, CA, H4A 3J1 |
GB | Cambridge, GB, CB2 0QQ |
GB | London, GB, EC1M 6BQ |
GB | London, GB, W1T 7HA |
GB | Manchester, GB, M20 4BX |
GB | Oxford, GB, OX3 7LE |
KR | Seoul, KR, 05505 |
KR | Seoul, KR, 06351 |
KR | Seoul, KR, 03080 |
PL | Bialystok, PL, 15-027 |
PL | Gdańsk, PL, 80-214 |
PL | Gliwice, PL, 44-101 |
PL | Kraków, PL, 30-688 |
PL | Łódź, PL, 90-302 |
PL | Lublin, PL, 20-090 |
PL | Opole, PL, 45-060 |
PL | Poznań, PL, 61-848 |
PL | Rzeszów, PL, 35-021 |
PL | Warszawa, PL, 02-507 |
PL | Warszawa, PL, 02-781 |
PL | Warszawa, PL, 04-141 |
TW | Kaohsiung, TW, 80756 |
TW | Taichung, TW, 40447 |
TW | Tainan City, TW, 70403 |
TW | Taipei, TW, 10002 |
TW | Taoyuan, TW, 333 |
US, AZ | Tucson, AZ, US, 85715 |
US, CA | West Hollywood, CA, US, 90048 |
US, MA | Boston, MA, US, 02215 |
US, MA | Boston, MA, US, 02114 |
US, MO | Saint Louis, MO, US, 63110 |
US, PA | Philadelphia, PA, US, 19124 |
US, TX | Dallas, TX, US, 75246 |
US, TX | Houston, TX, US, 77030 |
US, TX | San Antonio, TX, US, 78240 |
US, VA | Fairfax, VA, US, 22031 |
US, VA | Williamsburg, VA, US, 23188 |